Ginkgo Bioworks reports Q3 2026 results, announces first autonomous lab sale to Novo

Ginkgo Bioworks Holdings, Inc. reported results for the third quarter of 2026, ended September 30, 2026, on November 5, 2026. Third quarter revenue was $28 million, compared to $29 million in the same period a year earlier, a decrease of 6%, though it increased from $20 million in the second quarter of 2026.¹ GAAP net loss from continuing operations was $41 million, down from $73 million a year earlier, and Adjusted EBITDA was negative $22 million, improved from negative $53 million.¹

The company held $285 million in cash, cash equivalents and marketable securities as of September 30, 2026, after a third-quarter cash burn of $27 million.¹ Ginkgo reaffirmed its full-year 2026 total cash burn outlook of $125 million to $150 million.¹

The quarter's headline item was a new commercial deal. Ginkgo announced an autonomous lab sale to Novo, described as a top-tier pharma company, for Novo's new Waltham, Massachusetts R&D site.¹ The company sells RAC plus Catalyst systems to pharma, national labs, universities and the U.S. government, with customers including Novo, Pacific Northwest National Laboratory, the NSF and ARPA-H.¹

On the government side, Ginkgo disclosed an ARPA-H GIVE subcontract worth up to $17.5 million to put RACs and Catalyst into RNA-medicine manufacturing for the first time.¹ The company said the U.S. government is building out autonomous labs as national infrastructure through the Genesis Mission, the NSF's roughly $400 million Programmable Cloud Laboratories Test Bed, and the $1.5 billion X-Labs initiative, where Ginkgo is providing access to its Nebula lab, as announced by the White House Office of Science and Technology Policy on October 8.¹

On the services side, the company said 22 ADME customers signed in the third quarter through its ADME-One service, with 20 of them first-time Ginkgo customers.¹ Takeda, Argenx, Lundbeck and AbbVie founded Ginkgo's Antibody Developability Consortium, and GSK, Novartis and Biogen also signed new work.¹ The company said frontier AI labs including OpenAI are using its Cloud Lab for AI data generation.¹